Medtronic SPHERE Per-AF Post-Approval Study

Enrolling By Invitation
99 years or below
All
Phase N/A
1 Location

Brief description of study

The purpose of the study is to evaluate the long-term effectiveness and safety of the Sphere-9 Catheter and Affera Ablation System in a post-approval setting for the treatment of drug refractory, recurrent, symptomatic, persistent AF (episode duration less than one year).

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Medical Research
  • Age: 99 years or below
  • Gender: All

TBD

Updated on 24 Apr 2026. Study ID: 25-1500
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu For Cancer trials contact Penn Medicine's Cancer Trial Navigator at: PMCancerResearch@pennmedicine.upenn.edu or 215-349-8245

Study is selecting its participants from a population, or group of people, decided on by the researchers in advance.

Contact Office of Clinical Research